GeneXpert MTB/RIF

Mar 21, 2020

Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test

May 29, 2019

Cepheid Receives FDA Clearance for Extragenital Claims for Xpert® CT/NG Test

Apr 23, 2019

PrimeStore® MTM opens Sputum-free Molecular Screening for M. tuberculosis Infection

Apr 15, 2019

Cepheid Announces FleXible Cartridge Program

Dec 20, 2018

Cepheid Receives CE-IVD Clearance for Xpert® HBV Viral Load

Sep 24, 2018

Game Changing Tuberculosis Assay Validated for Illumina's MiSeq® Platform

Jul 26, 2018

Cepheid Receives FDA Clearance and CLIA Waiver for Xpert® Xpress Flu/RSV Test

May 02, 2018

Cepheid Receives FDA Clearance and CLIA Waiver for Xpert Xpress Strep A

Mar 22, 2018

World TB Day 2018: US Food and Drug Administration Clears PrimeStore® MTM, an Important New Device in the Worldwide Fight Against Mycobacterium Tuberculosis

Jan 09, 2018

Cepheid Receives FDA Clearance and CLIA Waiver for Xpert® Xpress Flu Test

Nov 14, 2017

Akonni Biosystems Awarded NIH Grant to Support Commercialization of a Low-Cost, Simple, Rapid Point-Of-Care Test for Tuberculosis and its Resistance to First-Line Drugs

Oct 05, 2017

Cepheid Expands Respiratory Disease Portfolio with Xpert Xpress Strep A

Aug 10, 2017

In-Vitro Diagnostics Markets, 2022 -Market is Further Expected to Reach US$83.03 Billion